Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy

Lacey JV, Sherman ME, Robboy SL, Mutter GL, Prat J, et al. Ovarian neoplasia. In: Robboy's pathology of the female reproductive tract. 2nd ed. Oxford: Churchill Livingstone Elsevier; 2009. p. 601.

Kroeger PT Jr, Dreapkin R. Pathogenesis and heterogeneity of ovarian cancer. Curr Opin Obstet Gynecol. 2017 Feb;29(1):26–34. https://doi.org/10.1097/GCO.0000000000000340 .

George SH, García R, Slomovitz BM. Ovarian Cancer: the fallopian tube as the site of origin and opportunities for prevention. Front Oncol. 2016;6:108. https://doi.org/10.3389/fonc.2016.00108 eCollection 2016.

The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaecol Can. 2014 Feb;36(2):133–140. doi: https://doi.org/10.1016/S1701-2163(15 ) 30659-9.

Zweemer RP, van Diest PJ, Verheijen RH, et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. GynecolOncol. 2000;76:45–50.

Nishida N, Murakami F, Higaki K. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cáncer. Pathol Int. 2016;66:337–42.

Singh, Naveena MD; Manchanda Ranjit, MD, Persistence of fimbrial tissue on the ovarian surface after salpingectomy. American Journal of Obstetrics & Gynecology 2017 425.e1-e16.

http://seer.cancer.gov/statfacts/html/ovary.html

Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube cancer in the United States. GynecolOncol. 2007;107:392.

© 2017 Programa de Cáncer de Ovario, INCAN.

Salehi F, Dunfield L, Phillips KP, et al. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev. 2008;11:301.

MA RBA, Hecht JL, Tworoger SS. Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol. 2010;171:45.

Tsilidis KK, Allen NE, Key TJ, et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European prospective investigation into Cancer and nutrition. Br J Cancer. 2011;105:1436.

Zhou B, Sun Q, Cong R, et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. GynecolOncol. 2008;108:641.

Stewart LM, Holman CD, Aboagye-Sarfo P, et al. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. GynecolOncol. 2013;128:260.

Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13:385.

Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod BioMed Online. 2009;19:398.

Tworoger SS, Fairfield KM, Colditz GA, et al. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol. 2007;166:894.

Song H, Dicks E, Ramus SJ, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian Cancer in the population. J ClinOncol. 2015;33:2901.

Sueblinvong T, Carney ME. Current understanding of risk factors for ovarian cancer. CurrTreat Options Oncol. 2009;10:67.

Soini T, Hurskainen R, Grénman S, et al. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. ObstetGynecol. 2014;124:292.

Whiteman DC, Siskind V, Purdie DM, Green AC. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev. 2003;12:42.

Whiteman DC, Murphy MF, Cook LS, et al. Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst. 2000;92:1172.

Myung SK, Ju W, Choi HJ, et al. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG. 2009;116:1697.

Ness RB, Cramer DW, Goodman MT, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2002;155:217.

Yin L, Grandi N, Raum E, et al. Meta-analysis: circulating vitamin D and ovarian cancer risk. GynecolOncol. 2011;121:369.

Kara C., Long Roche MD, Nadeem R Abu-Rustum MD, Mlica Nourmoussavi MD., Zivanovic, O. MD. Risk-reducing salpingectomy: Let us be opportunistic. Cancer. May 15. Volume 123, Issue 10 Pages: 1675–1876, 2017 https://doi.org/10.1002/cncr.30528 Epub 2017 Mar 23.

Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses. Health Studies FertilSteril. 2014;102:192.

Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative ovarian Cancer group. Am J Epidemiol. 1992;136:1184.

Cibula D, Widschwendter M, Májek O, Dusek L. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. HumReprodUpdate. 2011;17:55.